Table 2.
Comparison of laboratory parameters between the two groups.
| Test | Normal ranges | NG group | G group | P values |
|---|---|---|---|---|
| WBC (109/L) | 3.5–9.5 | 5.4 ± 2.4 | 5.4 ± 3.2 | 1 |
| Neutrophils (%) | 40–75 | 65.9 ± 13.9 | 66.3 ± 13.8 | 0.761 |
| Leukomonocytes (109/L) | 1.1–3.2 | 1.2 ± 0.6 | 1.1 ± 0.6 | 0.08 |
| Platelets (109/L) | 125–350 | 198.0 ± 78.2 | 188.4 ± 75.8 | 0.188 |
| CRP (mg/dL) | 0–0.6 | 2.5 ± 3.3 | 3.2 ± 3.8 | 0.044 |
| Procalcitonin (ng/ml) | <0.1 | 0.2 ± 0.8 | 0.7 ± 4.5 | 0.16 |
| D-dimer (µg/ml) | 0–1 | 2.0 ± 8.7 | 1.5 ± 3.1 | 0.346 |
| CK (U/L) | 26–140 | 112.9 ± 132.2 | 152.9 ± 344.2 | 0.152 |
| LDH (U/L) | 103–227 | 195.4 ± 85.6 | 231.0 ± 146.0 | < 0.001 |
| α-HBDH (U/L) | 72–182 | 152.0 ± 64.7 | 176.4 ± 98.3 | 0.004 |
| TBIL (µmol/L) | 2–20.4 | 9.9 ± 5.6 | 11.3 ± 12.4 | 0.169 |
| ALT (U/L) | 7–40 u /L | 27.4 ± 38.4 | 42.1 ± 120.3 | 0.128 |
| AST (U/L) | 13–35 | 26.4 ± 22.0 | 48.1 ± 188.9 | 0.144 |
| GGT (U/L) | 7–45 | 42.3 ± 72.3 | 45.8 ± 106.4 | 0.703 |
| Creatinine (µmol/L) | 41–73 | 79.6 ± 131.9 | 66.0 ± 24.0 | 0.066 |
| Urea (mmol/L) | 1.7–8.3 | 4.7 ± 3.6 | 4.6 ± 3.2 | 0.753 |
NG group: COVID-19 patients without gastrointestinal symptoms group; G Group: COVID-19patients with gastrointestinal symptoms; WBC: white blood cells count; CRP: C-reactive protein; CK: creatine kinase; LDH: lactate dehydrogenase; α-HBDH: α-butyrate dehydrogenase; TBIL: total bilirubin; ALT: alanine aminotransferase; AST: aspartic acid transferase; GGT: γ-glutamyl transferase.